Compound reference
Thymogen is investigated in immune-cell signaling and blood-cell development. These early mechanistic questions differ from demonstrated prevention of illness or recovery benefits in an animal-care formula.
Explore the selected studies, their findings and their limits.
A laboratory comparison of synthetic immune-related peptides examined blood-cell colony formation. Thymogen did not reproduce the stronger effect of the comparator peptide under the tested conditions. This illustrates why related thymic peptides are not interchangeable. Such experiments do not establish fewer infections or improved recovery in dogs.
The studies discussed here do not establish the safety or effectiveness of this catalog formula in dogs. Rat, mouse, cell-culture and human findings are not canine clinical results; they also do not establish absorption or effects from the listed oral formula.
For more information, contact info@aurevixpeptides.com.
Editorial review: September 23, 2026
